Skip to content
Open access

Serum VIP and IL‐1β Levels Are Associated With Anxiety and Depression in Patients With Parkinson's Disease: A Cross‐Sectional Study

Sep 2026 · Brain and Behavior · Vol 16 · 0 citations · 41 references
Medicine

TL;DR

This study evaluated whether circulating concentrations of vasoactive intestinal peptide, interleukin‐1β (IL‐1β), and tumor necrosis factor‐alpha (TNF‐α) differed according to the presence of anxiety and depressive symptoms among individuals with PD.

Abstract

Anxiety and depressive symptoms frequently accompany Parkinson's disease (PD), yet the biological processes underlying these affective complications and their potential peripheral indicators remain incompletely understood. This study evaluated whether circulating concentrations of vasoactive intestinal peptide (VIP), interleukin‐1β (IL‐1β), and tumor necrosis factor‐alpha (TNF‐α) differed according to the presence of anxiety and depressive symptoms among individuals with PD.

Read PDF

Similar papers

Open access Aug 2026

IL-1α and CRP as key inflammatory mediators linking neuropathic pain, anxiety, and depression in major depressive disorder

The findings highlight IL-1α and CRP as key inflammatory markers associated with the relationship between pain, anxiety, and depressive symptoms and suggest the potential relevance of inflammation-related pathways in the clinical assessment of pain within the context of MDD.

Cuizhen Zhu, Lin Cheng, Jian Cheng et al. · 0 citations
Case report Oct 2026

Anti-Inflammatory Agents: Can They Target Anhedonia in Depression?

Anti-inflammatory agents used adjunctively modestly reduced depressive symptoms and anhedonia in patients with CRP above 2 mg/L. However, they did not improve response or remission rates. CRP remains the best available biomarker for inflammatory depression but is nonspecific; routine screening is not yet warranted. For...

S. Beach · 0 citations
Open access Sep 2026

Interplay of neuropeptide Y, metabolic dysfunction, and inflammation in cognitive impairment of major depressive disorder: a sex-stratified study

A sex-specific pathway linking NPY, metabolic dysfunction, and inflammation to cognitive decline in MDD is revealed, and the integrated biomarker panel offers superior diagnostic utility.

Qian-Fa Yuan, Mohammed A. M. Elhassan, Hong-He Zhang et al. · 0 citations
Open access Aug 2026

Inflammation and neuropsychiatric symptoms in Parkinson's disease: a genetic association

Background There has been some evidence that neuroinflammation is involved in Parkinson's disease (PD) and in psychiatric disorders. Objective To explore the effects of IL-1β rs16944 on PD patients' neuropsychiatric symptoms. Methods Two hundred and eighty-one consecutive PD patients underwent a neurological and neurop...

A. Gonçalves, Alexandre Mendes, J. Damásio et al. · 0 citations
Sep 2026

TXNIP and NLRP3 inflammasome markers in major depressive disorder: Associations with remission status and verbal memory.

BACKGROUND Oxidative stress plays a role in the pathophysiology of depression and cognitive dysfunction. Oxidative stress induced NOD-like receptor 3(NLRP3) inflammasome and Thioredoxin-interacting protein (TXNIP) activation may contribute to neuroinflammation in depression. As oxidative stress contributes to insulin r...

Deniz Koca Yigit, E. Aydın, Mine Yalcinkaya Kara · 0 citations
Open access Sep 2026

The Relationship Between Dysglycemia and Dyslipidemia in First‐Episode, Untreated Chinese Patients With Major Depressive Disorder at Different Ages of Onset

Dysglycemia, a common ailment in MDD patients, lacks research regarding its variance across the age of onset (AOO). Therefore, we investigated the correlation between fasting blood glucose (FBG) abnormalities and blood lipids in first‐onset, untreated patients with MDD and to determine the factors that influence glycem...

Hang Tan, Zhan Wang, Jie Ma et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.